HomeCompareLIFS vs NOBL

LIFS vs NOBL: Dividend Comparison 2026

LIFS yields 666666.67% · NOBL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIFS wins by $8.275235618773884e+34M in total portfolio value
10 years
LIFS
LIFS
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full LIFS calculator →
NOBL
NOBL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NOBL calculator →

Portfolio growth — LIFS vs NOBL

📍 LIFS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIFSNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIFS + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIFS pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIFS
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, LIFS beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIFS + NOBL for your $10,000?

LIFS: 50%NOBL: 50%
100% NOBL50/50100% LIFS
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIFS buys
0
NOBL buys
0
No recent congressional trades found for LIFS or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIFSNOBL
Forward yield666666.67%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$8.275235618773884e+34M$28.0K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$899.19
Total dividends collected$8.275075881065991e+34M$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: LIFS vs NOBL ($10,000, DRIP)

YearLIFS PortfolioLIFS Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,120$420.00+$66.67MLIFS
2$415,506,651,117$415,435,306,334.37$12,357$458.31+$415506.64MLIFS
3$2,419,908,598,386,268$2,419,464,006,269,573.00$13,721$499.76+$2419908598.37MLIFS
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$15,227$544.58+$13171697643084.44MLIFS
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$16,885$593.02+$67004927492790120.00MLIFS
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$18,713$645.34+$318562277003514871808.00MLIFS
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$20,724$701.81+$1.415484168853553e+24MLIFS
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$22,938$762.73+$5.878130573362507e+27MLIFS
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$25,372$828.41+$2.2813793009840744e+31MLIFS
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$28,047$899.19+$8.275235618773884e+34MLIFS

LIFS vs NOBL: Complete Analysis 2026

LIFSStock

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation. The company was founded in 2012 and is based in Beverly Hills, California.

Full LIFS Calculator →

NOBLETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →
📬

Get this LIFS vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIFS vs SCHDLIFS vs JEPILIFS vs OLIFS vs KOLIFS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.